| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |